Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
250.59
-0.41 (-0.16%)
Feb 21, 2025, 4:00 PM EST - Market closed
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$305.86
Upside
+22.06%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $384 → $385 | Strong Buy | Maintains | $384 → $385 | +53.64% | Feb 18, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $310 → $300 | Buy | Maintains | $310 → $300 | +19.72% | Feb 14, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $275 → $284 | Hold | Maintains | $275 → $284 | +13.33% | Feb 14, 2025 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | +27.70% | Feb 14, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $300 | Buy | Reiterates | $300 | +19.72% | Feb 11, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $300 | Buy | Reiterates | $300 | +19.72% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +59.62% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | +27.70% | Jan 13, 2025 |
| Bernstein | Bernstein | Buy Maintains $314 → $310 | Buy | Maintains | $314 → $310 | +23.71% | Jan 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $296 | Buy | Reiterates | $296 | +18.12% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +59.62% | Nov 18, 2024 |
| Wolfe Research | Wolfe Research | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +59.62% | Nov 4, 2024 |
| Raymond James | Raymond James | Buy Maintains $275 → $298 | Buy | Maintains | $275 → $298 | +18.92% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $300 | Buy | Reiterates | $300 | +19.72% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $305 → $310 | Buy | Maintains | $305 → $310 | +23.71% | Nov 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.